Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2008-11-28
Original market date: See footnote 1
1997-06-16
Product name:
VIOKASE POWDER
DIN:
02230020 Electronic product monograph is not available
Company:
AXCAN PHARMA INC
597 Laurier Blvd
Mont St-Hilaire
Quebec
Canada
J3H 6C4
Class:
Human
Dosage form(s):
Powder
Route(s) of administration:
Oral
Number of active ingredient(s):
3
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
56:16.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)
Active ingredient group (AIG) number:See footnote5
0302964006
Active ingredient(s) | Strength |
---|---|
AMYLASE | 70000 UNIT / 0.7 G |
LIPASE | 16800 UNIT / 0.7 G |
PROTEASE | 70000 UNIT / 0.7 G |